Neurociencia del consumo y dependencia de sustancias psicoactivas
Neurociencia del consumo y dependencia de sustancias psicoactivas Neurociencia del consumo y dependencia de sustancias psicoactivas
3. PROCESOS BIOCONDUCTUALES SUBYACENTES A LAS FARMACODEPENDENCIASJaffe JH (1985) Drug addiction and drug abuse. In: Gilman AG, Goodman LS,Rall TW, eds. Goodman and Gilman's: The pharmacological basis of therapeutics,7a. ed. Nueva York, NY, MacMillan:522–573.Jaffe JH (1990) Drug addiction and drug use. In: Gilman AG y colab., eds.Goodman and Gilman's: The pharmacological basis of therapeutics, 8a. ed. NuevaYork, NY, Pergamon Press: 522–573.Johanson CE, Uhlenhuth EH (1978) Drug self-administration in humans.NIDA Research Monograph, 20:68–85.Johanson CE, Kilgore K, Uhlenhuth EH (1983) Assessment of dependencepotential of drugs in humans using multiple indices. Psychopharmacology,81:144–149.Koob GF y colab. (1989) Opponent process theory of motivation: neurobiologicalevidence from studies of opiate dependence. Neuroscience and BiobehavioralReviews, 13:135–140.Koob GF y colab. (1997) Opponent process model and psychostimulant addiction.Pharmacology, Biochemistry and Behavior, 57:513–521.Lewander T (1974) Effect of chronic treatment with central stimulants on brainmonoamines and some behavioral and physiological functions in rats, guineapigs, and rabbits. En: Usdin E, ed. Advances in biochemical psychopharmacology.Vol. 12. Neuropsychopharmacology of monoamines and their regulatory enzymes.Nueva York, NY, Raven Press:221–239.Marinelli M, Le Moal M, Piazza PV (1998) Sensitization to the motor effects ofcontingent infusions of heroin but not of kappa agonist RU 51599.Psychopharmacology (Berlín), 139:281–285.Montague PR, Dayan P, Sejnowski TJ (1996) A framework for mesencephalicdopamine systems based on predictive Hebbian learning. Journal of Neuroscience,16:1936–1947.O’Brien CP y colab. (1992) Classical conditioning in drug-dependent humans.Annals of the New York Academy of Sciences, 654:400–415.Paulson PE, Camp DM, Robinson TE (1991) Time course of transient behavioraldepression and persistent behavioral sensitization in relation to regionalbrain monoamine concentrations during amphetamine withdrawal in rats.Psychopharmacology (Berlín), 103:480–492.Pérez-Reyes M y colab. (1991) Clinical effects of daily methamphetamineadministration. Clinical Neuropharmacology, 14:352–358.Phillips AG, Fibiger HC (1979) Decreased resistance to extinction afterhaloperidol: implications for the role of dopamine in reinforcement.Pharmacology, Biochemistry and Behavior, 10:751–760.Phillips AG, Di Ciano P (1996) Behavioral sensitization is induced by intravenousself-administration of cocaine by rats. Psychopharmacology (Berlín),124:279–281.Piazza PV y colab. (1990) Individual reactivity to novelty predicts probability ofamphetamine self-administration. Behavioural Pharmacology, 1:339–345.Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine andamphetamine preferentially increase extracellular dopamine in the “shell” as63
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVAScompared with the “core” of the rat nucleus accumbens. Proceedings of theNational Academy of Science of the United States of America, 92:12 304–12 308.Post RM y colab. (1992) Conditioned sensitization to the psychomotor stimulantcocaine. Annals of the New York Academy of Sciences. 654:386–399.Robbins TW, Everitt BJ (1996) Neurobehavioural mechanisms of reward andmotivation. Current Opinion in Neurobiology, 6:228–236.Robinson TE, Becker JB (1986) Enduring changes in brain and behavior producedby chronic amphetamine administration: a review and evaluation of animalmodels of amphetamine psychosis. Brain Research Reviews, 11:157–198.Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitizationtheory of addiction. Brain Research Reviews, 18:247–291.Robinson TE, Kolb B (1997) Persistent structural modifications in nucleusaccumbens and prefrontal cortex neurons produced by previous experience withamphetamine. Journal of Neuroscience, 17:8491–8497.Robinson TE, Kolb B (1999) Alterations in the morphology of dendrites anddendritic spines in the nucleus accumbens and prefrontal cortex followingrepeated treatment with amphetamine or cocaine. European Journal ofNeuroscience, 11:1598–1604.Robinson TE, Berridge KC (2000) The psychology and neurobiology of addiction:an incentive-sensitization view. Addiction, 95(Supl 2):S91–S117.Schenk S, Partridge B (1997) Sensitization and tolerance in psychostimulantself-administration. Pharmacology, Biochemistry and Behavior, 57:543–550.Schultz W, Dayan P, Montague PR (1997) A neural substrate of prediction andreward. Science, 275:1593–1599.Sell LA y colab. (1999) Activation of reward circuitry in human opiate addicts.European Journal of Neuroscience, 11:1042–1048.Sell LA y colab. (2000) Neural responses associated with cue evoked emotionalstates and heroin in opiate addicts. Drug and Alcohol Dependence, 60:207–216.Sills TL, Crawley JN (1996) Individual differences in sugar consumption predictamphetamine-induced dopamine overflow in nucleus accumbens. EuropeanJournal of Pharmacology, 303:177–181.Sills TL, Onalaja AO, Crawley JN (1998) Mesolimbic dopaminergic mechanismsunderlying individual differences in sugar consumption and amphetaminehyperlocomotion in Wistar rats. European Journal of Neuroscience,10:1895–1902.Stewart J (2000) Pathways to relapse: the neurobiology of drug- and stressinducedrelapse to drug-taking. Journal of Psychiatry and Neuroscience,25:125–136.Stewart J, de Wit H, Eikelboom R (1984) Role of unconditioned and conditioneddrug effects in the self-administration of opiates and stimulants.Psychological Reviews, 91:251–268.Sutton MA, Karanian DA, Self DW (2000) Factors that determine a propensityfor cocaine-seeking behavior during abstinence in rats. Neuropsychopharmacology,22:626–641.64
- Page 33 and 34: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 35 and 36: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 37 and 38: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 39 and 40: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 42 and 43: 2. MECANISMOS CEREBRALES: NEUROBIOL
- Page 44 and 45: 2. MECANISMOS CEREBRALES: NEUROBIOL
- Page 46 and 47: 2. MECANISMOS CEREBRALES: NEUROBIOL
- Page 48 and 49: 2. MECANISMOS CEREBRALES: NEUROBIOL
- Page 51 and 52: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 53 and 54: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 55 and 56: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 57 and 58: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 59 and 60: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 61 and 62: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 63 and 64: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 65 and 66: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 67 and 68: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 69 and 70: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 71 and 72: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 73 and 74: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 75 and 76: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 77 and 78: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 79 and 80: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 81 and 82: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 83: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
- Page 88 and 89: Capítulo 4Psicofarmacología de la
- Page 90 and 91: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 92 and 93: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 94 and 95: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 96 and 97: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 98 and 99: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 100 and 101: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 102 and 103: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 104 and 105: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 106 and 107: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 108 and 109: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 110 and 111: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 112 and 113: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 114 and 115: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 116 and 117: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 118 and 119: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 120 and 121: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 122 and 123: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 124 and 125: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 126 and 127: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 128 and 129: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 130 and 131: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
- Page 132 and 133: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
3. PROCESOS BIOCONDUCTUALES SUBYACENTES A LAS FARMACODEPENDENCIASJaffe JH (1985) Drug addiction and drug abuse. In: Gilman AG, Goodman LS,Rall TW, eds. Goodman and Gilman's: The pharmacological basis of therapeutics,7a. ed. Nueva York, NY, MacMillan:522–573.Jaffe JH (1990) Drug addiction and drug use. In: Gilman AG y colab., eds.Goodman and Gilman's: The pharmacological basis of therapeutics, 8a. ed. NuevaYork, NY, Pergamon Press: 522–573.Johanson CE, Uhlenhuth EH (1978) Drug self-administration in humans.NIDA Research Monograph, 20:68–85.Johanson CE, Kilgore K, Uhlenhuth EH (1983) Assessment of <strong>de</strong>pen<strong>de</strong>ncepotential of drugs in humans using multiple indices. Psychopharmacology,81:144–149.Koob GF y colab. (1989) Opponent process theory of motivation: neurobiologicalevi<strong>de</strong>nce from studies of opiate <strong>de</strong>pen<strong>de</strong>nce. Neuroscience and BiobehavioralReviews, 13:135–140.Koob GF y colab. (1997) Opponent process mo<strong><strong>de</strong>l</strong> and psychostimulant addiction.Pharmacology, Biochemistry and Behavior, 57:513–521.Lewan<strong>de</strong>r T (1974) Effect of chronic treatment with central stimulants on brainmonoamines and some behavioral and physiological functions in rats, guineapigs, and rabbits. En: Usdin E, ed. Advances in biochemical psychopharmacology.Vol. 12. Neuropsychopharmacology of monoamines and their regulatory enzymes.Nueva York, NY, Raven Press:221–239.Marinelli M, Le Moal M, Piazza PV (1998) Sensitization to the motor effects ofcontingent infusions of heroin but not of kappa agonist RU 51599.Psychopharmacology (Berlín), 139:281–285.Montague PR, Dayan P, Sejnowski TJ (1996) A framework for mesencephalicdopamine systems based on predictive Hebbian learning. Journal of Neuroscience,16:1936–1947.O’Brien CP y colab. (1992) Classical conditioning in drug-<strong>de</strong>pen<strong>de</strong>nt humans.Annals of the New York Aca<strong>de</strong>my of Sciences, 654:400–415.Paulson PE, Camp DM, Robinson TE (1991) Time course of transient behavioral<strong>de</strong>pression and persistent behavioral sensitization in relation to regionalbrain monoamine concentrations during amphetamine withdrawal in rats.Psychopharmacology (Berlín), 103:480–492.Pérez-Reyes M y colab. (1991) Clinical effects of daily methamphetamineadministration. Clinical Neuropharmacology, 14:352–358.Phillips AG, Fibiger HC (1979) Decreased resistance to extinction afterhaloperidol: implications for the role of dopamine in reinforcement.Pharmacology, Biochemistry and Behavior, 10:751–760.Phillips AG, Di Ciano P (1996) Behavioral sensitization is induced by intravenousself-administration of cocaine by rats. Psychopharmacology (Berlín),124:279–281.Piazza PV y colab. (1990) Individual reactivity to novelty predicts probability ofamphetamine self-administration. Behavioural Pharmacology, 1:339–345.Pontieri FE, Tanda G, Di Chiara G (1995) Intravenous cocaine, morphine andamphetamine preferentially increase extracellular dopamine in the “shell” as63